XKRX:323990 (Korea (the Republic of))
Â
Ordinary Shares
â‚©
16050.00
(-1.53%)
Apr 25
Business Description
Vaxcell-Bio Therapeutics
ISIN : KR7323990002
Share Class Description:
XKRX:323990: Ordinary SharesCompare
Compare
Traded in other countries / regions
323990.Korea IPO Date
2020-09-22Description
Vaxcell-Bio Therapeutics is a bio-technology company engaged in the development of Cell-based and Protein-based Immunotherapeutics for the treatment of cancer.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 138.54 | |||||
| Equity-to-Asset | 0.98 | |||||
| Debt-to-EBITDA | -0.04 | |||||
| Piotroski F-Score | 1/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | -6.4 | |||||
| 3-Year EPS without NRI Growth Rate | -5.4 | |||||
| 3-Year FCF Growth Rate | -9.9 | |||||
| 3-Year Book Growth Rate | 1.5 |
Momentum Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 23.35 | |||||
| 9-Day RSI | 26.52 | |||||
| 14-Day RSI | 30.57 | |||||
| 6-1 Month Momentum % | 11.41 | |||||
| 12-1 Month Momentum % | -27.17 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 55.43 | |||||
| Quick Ratio | 55.33 | |||||
| Cash Ratio | 54.15 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -32.1 | |||||
| Shareholder Yield % | -0.05 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| FCF Margin % | -70112.15 | |||||
| ROE % | -31.59 | |||||
| ROA % | -30.44 | |||||
| ROIC % | -112.83 | |||||
| ROC (Joel Greenblatt) % | -379.14 | |||||
| ROCE % | -30.81 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 22928.58 | |||||
| PB Ratio | 4.42 | |||||
| Price-to-Tangible-Book | 4.43 | |||||
| EV-to-EBIT | -31.21 | |||||
| EV-to-EBITDA | -32.49 | |||||
| EV-to-Revenue | 23271.58 | |||||
| EV-to-FCF | -34.72 | |||||
| Price-to-Net-Current-Asset-Value | 7.42 | |||||
| Price-to-Net-Cash | 7.6 | |||||
| Earnings Yield (Greenblatt) % | -3.2 | |||||
| FCF Yield % | -2.6 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Vaxcell-Bio Therapeutics Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil â‚©) | 13.723 | ||
| EPS (TTM) (â‚©) | -499.17 | ||
| Beta | 1.7 | ||
| Volatility % | 48.31 | ||
| 14-Day RSI | 30.57 | ||
| 14-Day ATR (â‚©) | 951.327807 | ||
| 20-Day SMA (â‚©) | 17930 | ||
| 12-1 Month Momentum % | -27.17 | ||
| 52-Week Range (â‚©) | 14350 - 42873.685878 | ||
| Shares Outstanding (Mil) | 22.99 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 1 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Vaxcell-Bio Therapeutics Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Vaxcell-Bio Therapeutics Stock Events
| Event | Date | Price(â‚©) | ||
|---|---|---|---|---|
| No Event Data | ||||
Vaxcell-Bio Therapeutics Frequently Asked Questions
What is Vaxcell-Bio Therapeutics(XKRX:323990)'s stock price today?
The current price of XKRX:323990 is â‚©16050.00. The 52 week high of XKRX:323990 is â‚©42873.69 and 52 week low is â‚©14350.00.
When is next earnings date of Vaxcell-Bio Therapeutics(XKRX:323990)?
The next earnings date of Vaxcell-Bio Therapeutics(XKRX:323990) is .
Does Vaxcell-Bio Therapeutics(XKRX:323990) pay dividends? If so, how much?
Vaxcell-Bio Therapeutics(XKRX:323990) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers